# Early Angiotensin II in the Emergency Department

> **NCT06693726** · PHASE4 · RECRUITING · sponsor: **Brett A Faine** · enrollment: 20 (estimated)

## Conditions studied

- Septic Shock

## Interventions

- **DRUG:** Angiotensin II Infusion

## Key facts

- **NCT ID:** NCT06693726
- **Lead sponsor:** Brett A Faine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-01
- **Primary completion:** 2026-08-31
- **Final completion:** 2026-11-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06693726

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06693726, "Early Angiotensin II in the Emergency Department". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06693726. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*